Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Update

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 33,900 shares, a decline of 38.1% from the December 31st total of 54,800 shares. Based on an average daily volume of 343,700 shares, the short-interest ratio is presently 0.1 days.

Daiichi Sankyo Trading Down 2.5 %

DSNKY traded down $0.71 on Friday, reaching $27.94. 211,670 shares of the company traded hands, compared to its average volume of 192,069. Daiichi Sankyo has a one year low of $25.11 and a one year high of $42.48. The firm has a fifty day simple moving average of $28.49 and a two-hundred day simple moving average of $32.96.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.22 earnings per share for the quarter.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Read More

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.